SIRT or sorafenib in patients with locally advanced HCC: SARAH and SIRveNIB trials
SIRT or sorafenib in patients with locally advanced HCC: SARAH and SIRveNIB trials
Dr. Mohamed Bouattour
Dr. Mohamed Bouattour from Hôpital Beaujon, APHP Clichy, France, discusses the SARAH and SIRveNIB trials in locally advanced HCC
Expert View |
5 min
I agree that this educational programme:
Was valuable to me:
1/3
Other programmes of interest
Other programmes developed by Dr. Mohamed Bouattour

Dr. Mohamed Bouattour
Hepatologist and Gastroenterologist
Beaujon University Hospital
France